Table 3.
Univariate and multivariate Cox regression analyses of potential prognostic factor for disease-specific survival (DSS) in patients with serous ovarian carcinoma
| Covariate | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
|
SALL4/ALDH1A1 coexpression High versus Low |
2.689 (0.974- 7.426) | 0.056 | 2.578 (0.909- 7.311) | 0.075 |
| Histological grade | 0.045 | 0.071 | ||
| II versus I | 0.205 (0.120- 2.228) | 0.970 | 0.100 (0.020- 2.20) | 0.968 |
| III versus I | 5.002 (1.409- 17.751) | 0.013 | 4.471 (1.249- 16.010) | 0.021 |
| VI metastasis | 0.265 (0.079- 0.886) | 0.031 | – | – |
| Vagina involvement | 0.319 (0.103- 0.993) | 0.049 | – | – |
| Cervix involvement | 0.214 (0.067- 0.687) | 0.010 | – | – |
| Myometrium involvement | 0.290 (0.092- 0.916) | 0.035 | – | – |
| Post-cul-de-sac involvement | 0.262 (0.083- 0.830) | 0.023 | – | – |
| Distant metastasis | 0.114 (0.026- 0.507) | 0.004 | – | – |
| Tumor recurrence | 0.015 (0.000- 0.985) | 0.049 | – | – |
H-score histological score
Values in bold are statistically significant
The variables with P value less than 0.05 and HR more than 1.0 were included in multivariable analyses HR hazard ratio, CI confidence interval